Mosedipimod Recruiting Phase 2 Trials for COVID-19 Pneumonia / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04569227Prevention of COVID-19 Infection to Severe Pneumonia or ARDS